North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Results
Looking for
Trastuzumab
found
15 matches
Open monograph to display formulary status
BNF Category
Trastuzumab
Malignant disease and immunosuppression - Trastuzumab - 08.01.05
Trastuzumab
deruxtecan
(Enhertu)
Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
Trastuzumab
emtansine
(Kadcyla
®
)
(S/C injection)
Malignant disease and immunosuppression - Trastuzumab - 08.01.05
Neratinib
(Nerlynx
®
)
Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
Pertuzumab
(Perjeta
®
)
Malignant disease and immunosuppression - Trastuzumab - 08.01.05
Tucatinib
(Tukysa
®
)
Malignant disease and immunosuppression - Protein kinase inhibitors - 08.01.05
Links
Link to Drug Section
Link to document
NICE TA208: Gastric cancer (HER2-positive metastatic) - trastuzumab (08.01.05)
NICE TA34: Breast cancer - trastuzumab (08.01.05)
NICE TA458 Trastuzumab emtansine for treating HER2-positive advanced breast cancer after trastuzumab and a taxane (08.01.05)
NICE TA509: Pertuzumab with trastuzumab and docetaxel for treating HER2-positive breast cancer (08.01.05)
NICE TA612: Neratinib for extended adjuvant treatment of hormone receptor-positive, HER2-positive early stage breast cancer after adjuvant trastuzumab (08.01.05)
NICE TA632: Trastuzumab emtansine for adjuvant treatment of HER2-positive early breast cancer (08.01.05)
NICE TA704: Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 2 or more anti-HER2 therapies (08.01.05)
NICE TA786: Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapies (08.01.05)
SubSection Titles / notes
Trastuzumab
- (08.01.05)